The Seer spinoff recently closed a $46 million funding round that it is using to support efforts in nucleic acid, proteomic, and metabolomic biomarker discovery.
Read the full article in GenomeWeb here.
April 19, 2024
PrognomiQ Aims to Launch Multiomic Lung Cancer Screening Test Buoyed by Positive Early Data
March 1, 2024
Multi-Omics Could be Key in Expanding Liquid Biopsy
July 13, 2023
Apparently Getting Smarter Makes Us Healthier: AI And Data Analysis Revolutionize Healthcare